Indogulf Cropsciences IPO
Historical offer record. This offer is closed for applications. Prices and subscriptions describe the past offer; GMP observations are unofficial past records, not current quotes or listing predictions.
Data provider: FinAPI. This is a third-party summary, not an official prospectus. Read our data limitations and editorial policy.
No GMP observations are available for this historical offer record. No premium or listing-gain estimate is shown.
Price band
₹105 – ₹111
Lot size
135 shares
Offer application amount
₹14,985
Issue size
₹200 Cr
Historical offer amount for 1 lot at the upper issue price. Confirm the lot size and application terms in the issuer prospectus.
Reported IPO schedule
| Open date | 26 Jun 2025 |
| Close date | 30 Jun 2025 |
| Allotment finalisation | 1 Jul 2025 |
| Refund initiation | 2 Jul 2025 |
| Shares credited to demat | 2 Jul 2025 |
| Reported listing date | 3 Jul 2025 |
Issue size
About Indogulf Cropsciences
Indogulf Cropscience Limited is one of the leading companies in terms of manufacturing protection, production plant nutrients, and biologicals in India. Crop protection, plant nutrients, and biologicals are the three main categories by which they operate. They serve both retail and institutional customers, with a focus on enhancing crop yield. They provide a wide range of products, including specialized items, that are offered across all three areas of business.
Company summary supplied by FinAPI. Read the prospectus for the issuer's disclosures and audited financials.
Offer documents and primary references
Read the issuer's offer document and any corrigenda for the full disclosures. A third-party details page is a summary; SEBI filing access does not imply an endorsement of the offer or this website.
IPO information is sourced from public feeds and shown for general information only. It is not a recommendation to apply for this or any IPO. IPOs are equity investments and carry market risk; listing gains are not guaranteed and SME IPOs are especially volatile. Grey Market Premium (GMP) is unofficial and not endorsed by SEBI or the exchanges. Equity IPOs are applied for through a demat and trading account, not through mutual fund distribution services. Read the RHP and consult a SEBI-registered investment adviser before investing.